December 06, 2021
A Greek Orthodox priest and hedge fund founder who defeated fraud scheme claims in the U.S. Securities and Exchange Commission's short-and-distort case moved Friday to toss a handful of claims for which a jury found him liable, arguing that his statements about two pharmaceutical companies didn't affect their stock prices.
November 05, 2021
A Boston federal jury on Friday absolved a Greek Orthodox priest of some fraud claims in a U.S. Securities and Exchange Commission suit alleging he launched a short-and-distort scheme through his hedge fund aimed at tanking a biotech company's stock price.
November 03, 2021
A Greek Orthodox priest tried to turn the tables on the U.S. Securities and Exchange Commission during closing arguments Wednesday in his short-selling fraud trial, telling a Boston jury that the government's case was built on a biotech's campaign to silence his hedge fund's broadsides targeting the company.
November 01, 2021
A Greek Orthodox priest tried to spark investor panic about Ligand Pharmaceuticals Inc. by telling shareholders to "run, Bambi, run" from the drug company while his hedge fund held a large short position on the stock, a Boston federal jury heard Monday.
October 29, 2021
A Greek Orthodox priest acted like a "bully" by repeatedly pushing false claims about a California biotech that drove down its stock price, the company's CEO told a Boston jury Friday in the U.S. Securities and Exchange Commission's suit.
December 17, 2020
A Greek Orthodox priest facing a short-selling suit by the U.S. Securities and Exchange Commission appears headed for trial after a Massachusetts federal judge on Thursday pushed back on his claim that he can't be liable because the stock price in question didn't drop.
October 01, 2020
A Massachusetts priest on Wednesday asked a federal judge to absolve him of claims by the U.S. Securities and Exchange Commission that he raked in $1.3 million by driving down the price of a pharmaceutical stock and then betting the other way.
March 18, 2020
A Massachusetts federal judge on Wednesday admonished a LibbyHoopes PC attorney for the "hardball tactic" of threatening to sue a Greek Orthodox priest unless he recanted statements made to the U.S. Securities and Exchange Commission in its fraud investigation of his client, a fellow clergy member.
March 09, 2020
The U.S. Securities and Exchange Commission has accused a priest facing stock fraud charges of attempting to influence the testimony of a potential witness by threatening to sue him unless he recanted earlier statements to the agency and paid $10,000, according to a court filing.
February 20, 2020
Ligand Pharmaceuticals joined the U.S. Securities and Exchange Commission's call Wednesday to sanction a Greek Orthodox priest facing a short-selling suit for trying to "poison the well" with selective leaks to a Barron's reporter of confidential documents.